FDA Should Loosen Leash On Responding To Off-Label Info Requests, Industry Says
This article was originally published in The Gray Sheet
Executive Summary
The standard in a recent FDA draft guidance for how companies should respond to unsolicited public requests for off-label product information is too restrictive, firms say.
You may also be interested in...
Off-Label Questions, Online: FDA Explains How To Handle Them
FDA draft guidance weighs in on web communications, saying that firms must answer off-label-information questions privately, even if the questions arise in a public online forum.
To Tweet Or Not To Tweet? Social Media Marketing Guidance Is There If You Look For It, Experts Say
Device and drug firms waiting for FDA to issue guidance on how best to use social media for marketing and promotion can look instead at existing regulations both in and outside the agency, experts said recently.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.